Literature DB >> 2983121

A monoclonal antibody that neutralizes poliovirus by cross-linking virions.

A A Thomas, P Brioen, A Boeyé.   

Abstract

The neutralization of type 1 poliovirus by monoclonal antibody 35-1f4 was studied. The virions were rapidly linked by antibody into oligomers and larger aggregates, followed by slow redistribution of antibody between the immune complexes. The antibody content and infectivity of immune complexes were determined. Remaining single virions were fully infectious and free of antibody. The oligomers and larger aggregates did not significantly contribute to the residual infectivity, which therefore correlated with the number of remaining single virions. Papain digestion of neutralized poliovirus released fully infectious, antibody-free virions from the immune complexes. Anti-immunoglobulin antibodies reneutralized these virions. Polymerization was shown to occur even at virus concentrations of less than 10(3) PFU per ml.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983121      PMCID: PMC254753     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Biophysical studies of the interactions between the viruses of tobacco mosaic and tomato bushy stunt and their rabbit antisera.

Authors:  C J BRADISH; L V CRAWFORD
Journal:  Virology       Date:  1960-05       Impact factor: 3.616

2.  A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus.

Authors:  R DULBECCO; M VOGT; A G STRICKLAND
Journal:  Virology       Date:  1956-04       Impact factor: 3.616

3.  Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction.

Authors:  B Mandel
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.

Authors:  E A Emini; P Ostapchuk; E Wimmer
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

6.  Hybridoma antibodies to poliovirus N and H antigen.

Authors:  P Brioen; R J Sijens; R Vrijsen; B Rombaut; A A Thomas; A Jackers; A Boeyé
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.

Authors:  J Icenogle; S F Gilbert; J Grieves; J Anderegg; R Rueckert
Journal:  Virology       Date:  1981-11       Impact factor: 3.616

8.  Neutralization of poliovirus by antibody-mediated polymerization.

Authors:  P Brioen; D Dekegel; A Boeyé
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

9.  A simple quantitative protein A micro-immunoprecipitation method; assay of antibodies to the N and H antigens of poliovirus.

Authors:  R Vrijsen; B Rombaut; A Boeyé
Journal:  J Immunol Methods       Date:  1983-04-29       Impact factor: 2.303

10.  Poliovirus neutralization and the percentage law. Brief report.

Authors:  P Brioen; A Boeyé
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

View more
  15 in total

1.  Valency of antibody binding to enveloped virus particles as determined by surface plasmon resonance.

Authors:  Sam A Hardy; Nigel J Dimmock
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  Insights into neutralization of animal viruses gained from study of influenza virus.

Authors:  M C Outlaw; N J Dimmock
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

3.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.

Authors:  F M Ruggeri; H B Greenberg
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments.

Authors:  R J Colonno; P L Callahan; D M Leippe; R R Rueckert; J E Tomassini
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  Relationship between poliovirus neutralization and aggregation.

Authors:  A A Thomas; R Vrijsen; A Boeyé
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion.

Authors:  K Wetz; P Willingmann; H Zeichhardt; K O Habermehl
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

7.  Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes.

Authors:  Z Che; N H Olson; D Leippe; W M Lee; A G Mosser; R R Rueckert; T S Baker; T J Smith
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  Monoclonal antibodies that disrupt poliovirus only at fever temperatures.

Authors:  I Delaet; A Boeyé
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection.

Authors:  Guo-hui Chang; Yan-jun Luo; Xiao-yan Wu; Bing-yin Si; Lei Lin; Qing-yu Zhu
Journal:  Virol J       Date:  2010-05-26       Impact factor: 4.099

10.  Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies.

Authors:  Siu-Kei Chow; Cameron Smith; Thomas MacCarthy; Mary Ann Pohl; Aviv Bergman; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.